vTv Therapeutics Inc - Class A —— 资产负债表 (NASDAQ:VTVT) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 14.79 M25.47 M33.24 M11.02 M38.27 M89.9 M 负债总额 11 M10.25 M27.4 M29.57 M23.96 M25.46 M 权益总额 -80.1 M-9.74 M-10.74 M-24.68 M14.3 M64.44 M 负债及股东权益总额 14.79 M25.47 M33.24 M11.02 M38.27 M89.9 M 总债务 915 K932 K224 K191 K0— 净债务 -4.83 M-12.48 M-11.9 M-9.26 M-36.75 M—

新闻

Evercore ISI首次覆盖vTv Therapeutics股票,给予跑赢大盘评级

Evercore ISI initiates vTv Therapeutics stock with outperform rating

BTIG重申买入评级,维持vTv Therapeutics目标价49美元

BTIG reiterates Buy on vTv Therapeutics stock, $49 target maintained

VTv Stock: Cadisegliatin's Phase 3 CATT1 Readout Is The Next Catalyst (NASDAQ:VTVT)

vTv Therapeutics扩大与诺华生物制药的HPP737许可协议

vTv Therapeutics expands HPP737 license agreement with Newsoara Biopharma

vTv将PDE4抑制剂的Newsoara许可协议扩展至全球范围

vTv expands Newsoara license deal for PDE4 inhibitor to global rights

Roth/MKM 对 vTv Therapeutics 股票启动覆盖并给予"买入"评级

Roth/MKM initiates coverage on vTv Therapeutics stock with Buy rating

This MasTec Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Decoy Therapeutics (NASDAQ:DCOY), e.l.f. Beauty (NYSE:ELF)